In-depth phenotypic characterization, detailed treatment protocols, and a comprehensive review of published NR4A2 cases offer a thorough understanding of patients afflicted with intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism. This evidence concerns the gene NR4A2 and Parkinson disease.